Facilitating the translation of evidence into best practice: Optimising the pharmacological management of inflammatory arthritis

Description

CATAG has developed this document to facilitate and support the translation of best available evidence into practice for the management of patients with inflammatory arthritis.┬áThe document summarises the recommendations from the ‘Australian Living Guideline for the Pharmacological Management of Inflammatory Arthritis’ for patients who have been diagnosed with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis.

This will assist good governance and decision-making for health service organisations, medicines governance committees and health professionals. It can be used in conjunction with formulary decisions and recommendations.

Download resource

Download (347.17 KB, PDF)

Published date

4 July 2023

Resource type

Evidence into practice

Governance topic

bDMARDs